Skip to main content
Caplight Logo









PT Medlinx Asia Teknologi

PT Medlinx Asia Teknologi

Private
IndonesiaHealthcare & Life Scienceshttps://medlinx.co.id/

Company Overview

PT Medlinx Asia Teknologi operates in Healthcare & Life Sciences and is based in Indonesia. It was founded in 2020.

PT Medlinx Asia Teknologi is a health technology company that provides digital healthcare solutions, including the izidok electronic medical record platform for independent doctors and clinics in Indonesia.

Sector

Healthcare & Life Sciences

Verticals

EHR & EMR, InsurTech, Revenue Cycle, NLP & Conversational AI, Pharma Supply Chain

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Marketplace Commission

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

PT Medlinx Asia Teknologi Comparables

Compare PT Medlinx Asia Teknologi with similar companies based on industry and business-model similarity.

PT Medlinx Asia Teknologi comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Smarter Health
79%
MiyaHealth
78%
PT Trustmedis Indonesia
78%
Book a demo to see all comparables

For institutional investors. Book with your work email.

PT Medlinx Asia Teknologi Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for PT Medlinx Asia Teknologi. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

PT Medlinx Asia Teknologi Filings

Explore SEC and related filing metadata, where available.

PT Medlinx Asia Teknologi filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about PT Medlinx Asia Teknologi's valuation, stock price, and market status.

Is PT Medlinx Asia Teknologi a public or private company?

PT Medlinx Asia Teknologi is a private company.

What is the current stock price of PT Medlinx Asia Teknologi?

PT Medlinx Asia Teknologi is a private company, so its shares have no public market price. Caplight tracks PT Medlinx Asia Teknologi's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is PT Medlinx Asia Teknologi worth (valuation)?

Valuation information for PT Medlinx Asia Teknologi is not publicly available.

Can I buy PT Medlinx Asia Teknologi stock?

PT Medlinx Asia Teknologi shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was PT Medlinx Asia Teknologi's last funding round?

Funding round information for PT Medlinx Asia Teknologi is not publicly available.

Who are the main investors in PT Medlinx Asia Teknologi?

Investor information for PT Medlinx Asia Teknologi is not publicly disclosed.

Will PT Medlinx Asia Teknologi IPO soon?

No public IPO plans have been announced for PT Medlinx Asia Teknologi.

How can I track PT Medlinx Asia Teknologi secondary market activity?

Caplight tracks bids, offers, and trades in PT Medlinx Asia Teknologi's shares on secondary markets.

Firmographic Details

HeadquartersIndonesia
Employee Range53
Year Founded2020
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?